Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase NA 1Phase 3 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Genitourinary 1CNS 1Breast 1

Conditions

Fatigue 1Brain Neoplasms 1

Interventions

Radiotherapy 64Temozolomide 59Vincristine 33Cyclophosphamide 32Carboplatin 30Radiosurgery 26Etoposide 25Cisplatin 25Lomustine 24Magnetic Resonance Spectroscopy 19Filgrastim 17Doxorubicin 15Bevacizumab 15Radiation 13Specimen Handling 12Granulocyte Colony-Stimulating Factor 12Surgical Procedures, Operative 11Isotretinoin 11Melphalan 10Carmustine 10Procarbazine 9Platinum 9Peripheral Blood Stem Cell Transplantation 9Chemotherapy, Adjuvant 9etoposide phosphate 7Topotecan 71,2-diaminocyclohexaneplatinum II citrate 7sargramostim 6Thiotepa 6Radiotherapy, Intensity-Modulated 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Modafinil × CNS × Clear all
NCT00418691 2020-09-23

Effects of Methylphenidate Versus Sustained Release Methylphenidate on Cognitive Functioning

M.D. Anderson Cancer Center

Phase 3 Terminated
34 enrolled 7 charts
CNS

Brain Neoplasms, Fatigue

Data powered by HemOnc (CC BY 4.0) Colophon âš¡